Drugmakers Pfizer and Valneva are one step closer to obtaining FDA approval for what would be the first Lyme disease vaccine after publishing positive results from a phase 3 trial, the companies announced July 17.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
